We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
DaVita Inc | NYSE:DVA | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.85 | 1.36% | 137.80 | 138.88 | 136.44 | 136.90 | 562,367 | 22:34:05 |
The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of DaVita HealthCare Partners Inc. (“DaVita” or the “Company”) (NYSE: DVA). DaVita is a Denver, Colorado-based company that provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease.
The Firm’s investigation relates to a U.S. Department of Justice announcement that DaVita had agreed to pay $350 million for allegedly violating several provisions of the False Claims Act, including persuading physicians to refer patients to DaVita by offering kickbacks. The Company has also agreed to a Civil Forfeiture of $39 million, based upon conduct related to joint venture transactions entered into in Colorado.
If you currently own DaVita common stock and are interested in discussing your rights, or have information relating to this investigation, please contact Kip B. Shuman or Rusty E. Glenn at (303) 861-3003 or email Mr. Shuman at kip@shumanlawfirm.com or email Mr. Glenn at rusty@shumanlawfirm.com.
The Shuman Law Firm represents investors throughout the nation, concentrating its practice in stockholder litigation.
THE SHUMAN LAW FIRMKip B. Shuman, Esq.Rusty E. Glenn, Esq.Tel: 303-861-3003Fax: 303-536-7849Email: kip@shumanlawfirm.comEmail: rusty@shumanlawfirm.comWeb: www.shumanlawfirm.com
1 Year DaVita Chart |
1 Month DaVita Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions